🚀 VC round data is live in beta, check it out!
Bayer SA Valuation Multiples
Discover revenue and EBITDA valuation multiples for Bayer SA and similar public comparables like InnoCare Pharma, Viking Therapeutics, Shijiazhuang Yiling, Tianjin Pharma and more.
Bayer SA Overview
About Bayer SA
Bayer SA is a Peru-based company. It is a research company focused on the life sciences. The company operates in various business segments that are Pharmaceuticals, which focuses on prescription products, for cardiology and women's healthcare, and on specialty therapeutics; Consumer Health, which markets mainly nonprescription products in the dermatology, nutritional supplement, analgesic, gastrointestinal, cold, and other; and Crop Science segment which generates maximum revenue, is engaged in development, production, and marketing of seeds, and plant traits, crop protection, digital solutions, and customer services to promote sustainable agriculture. Geographically, the company generates key revenue from the United States of America and the rest from China, Brazil, and other countries.
Founded
1863
HQ
Employees
99.7K
Website
Sectors
Financials (FY)
EV
$42B
Bayer SA Stock Performance
Bayer SA has current market cap of $4B, and enterprise value of $42B.
Market Cap Evolution
Bayer SA's stock price is $4.16.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $42B | $4B | 1.5% | XXX | XXX | XXX | — |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialBayer SA Valuation Multiples
Bayer SA Financial Valuation Multiples
As of April 21, 2026, Bayer SA has market cap of $4B and EV of $42B.
Equity research analysts estimate Bayer SA's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $4B | XXX | $4B | XXX | XXX | XXX |
| EV (current) | $42B | XXX | $42B | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Bayer SA Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Bayer SA Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Bayer SA | XXX | XXX | XXX | XXX | XXX | XXX |
| InnoCare Pharma | XXX | XXX | XXX | XXX | XXX | XXX |
| Viking Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Shijiazhuang Yiling | XXX | XXX | XXX | XXX | XXX | XXX |
| Tianjin Pharma | XXX | XXX | XXX | XXX | XXX | XXX |
| Peptron | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Bayer SA M&A Activity
Bayer SA acquired XXX companies to date.
Last acquisition by Bayer SA was on XXXXXXXX, XXXXX. Bayer SA acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Bayer SA
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialBayer SA Investment Activity
Bayer SA invested in XXX companies to date.
Bayer SA made its latest investment on XXXXXXXX, XXXXX. Bayer SA invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Bayer SA
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Bayer SA
| When was Bayer SA founded? | Bayer SA was founded in 1863. |
| Where is Bayer SA headquartered? | Bayer SA is headquartered in United States. |
| How many employees does Bayer SA have? | As of today, Bayer SA has over 99K employees. |
| Is Bayer SA publicly listed? | Yes, Bayer SA is a public company listed on Lima Stock Exchange. |
| What is the stock symbol of Bayer SA? | Bayer SA trades under BAYERI1 ticker. |
| When did Bayer SA go public? | Bayer SA went public in 1987. |
| Who are competitors of Bayer SA? | Bayer SA main competitors are InnoCare Pharma, Viking Therapeutics, Shijiazhuang Yiling, Tianjin Pharma. |
| What is the current market cap of Bayer SA? | Bayer SA's current market cap is $4B. |
| Is Bayer SA profitable? | No, Bayer SA is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.